Imunon (IMNN)
1.59
-0.08 (4.79%)
Upcoming Events
Latest Headlines
Form 4 Imunon, Inc. For: Jul 17 Filed by: Tardugno Michael H
July 21, 2026 4:17 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 17 Filed by: Eylward Susan
July 21, 2026 4:16 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 17 Filed by: Faller Douglas Vincent
July 21, 2026 4:15 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 17 Filed by: Lindborg Stacy
July 21, 2026 4:14 PM - SEC Filing
Imunon reports Phase 2 MRD data for IMNN-001 in ovarian cancer
July 21, 2026 9:00 AM - StreetInsider
IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer
July 21, 2026 9:00 AM - StreetInsider
Form 4 Imunon, Inc. For: Jul 02 Filed by: Tardugno Michael H
July 7, 2026 5:05 PM - SEC Filing
Form 3 Imunon, Inc. For: Jul 01 Filed by: Blacher Joshua
July 7, 2026 5:01 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 02 Filed by: Eylward Susan
July 7, 2026 4:58 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 02 Filed by: Faller Douglas Vincent
July 7, 2026 4:57 PM - SEC Filing
Form 4 Imunon, Inc. For: Jul 02 Filed by: Lindborg Stacy
July 7, 2026 4:56 PM - SEC Filing
Imunon names new interim CFO as predecessor retires
June 30, 2026 4:40 PM - StreetInsider
Form 8-K Imunon, Inc. For: Jun 29
June 30, 2026 4:32 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 25 Filed by: Faller Douglas Vincent
June 29, 2026 4:36 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 25 Filed by: Eylward Susan
June 29, 2026 4:34 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 25 Filed by: Tardugno Michael H
June 29, 2026 4:23 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 25 Filed by: Lindborg Stacy
June 29, 2026 4:21 PM - SEC Filing
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026 8:35 AM - StreetInsider
Form 4 Imunon, Inc. For: Jun 18 Filed by: Tardugno Michael H
June 23, 2026 7:59 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 18 Filed by: Lindborg Stacy
June 23, 2026 4:18 PM - SEC Filing
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026 8:35 AM - StreetInsider
IMUNON's Phase 3 ovarian cancer trial cleared to continue by safety panel
June 23, 2026 8:00 AM - StreetInsider
IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification
June 23, 2026 8:00 AM - StreetInsider
IMUNON to Present at the Life Sciences Investor Forum on June 25th
June 22, 2026 4:15 PM - StreetInsider
Form S-8 Imunon, Inc.
June 17, 2026 4:16 PM - SEC Filing
Form 8-K Imunon, Inc. For: Jun 16
June 16, 2026 5:30 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 05 Filed by: Tardugno Michael H
June 9, 2026 5:16 PM - SEC Filing
Form 4 Imunon, Inc. For: Jun 05 Filed by: Lindborg Stacy
June 9, 2026 4:14 PM - SEC Filing
IMUNON secures $10 million financing for ovarian cancer trial
June 4, 2026 8:03 AM - StreetInsider
Form 8-K Imunon, Inc. For: Jun 01
June 4, 2026 8:01 AM - SEC Filing
IMUNON Announces Up to $10 Million Cash Financing
June 4, 2026 8:00 AM - Globe NewsWire
Form 4 Imunon, Inc. For: May 22 Filed by: Tardugno Michael H
May 27, 2026 4:22 PM - SEC Filing
Form 4 Imunon, Inc. For: May 22 Filed by: Pellizzari Christine A
May 27, 2026 4:14 PM - SEC Filing
Form 4 Imunon, Inc. For: May 22 Filed by: Dentzer James E
May 27, 2026 4:13 PM - SEC Filing
Form 4 Imunon, Inc. For: May 22 Filed by: Braun Donald P
May 27, 2026 4:12 PM - SEC Filing
Form 4 Imunon, Inc. For: May 22 Filed by: Fritz Frederick J.
May 27, 2026 4:12 PM - SEC Filing
Form 4 Imunon, Inc. For: May 22 Filed by: Lindborg Stacy
May 27, 2026 4:11 PM - SEC Filing
Form SCHEDULE 13G/A Imunon, Inc. Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 11:22 AM - SEC Filing
Imunon (IMNN) Misses Q1 EPS by 84c
May 12, 2026 8:48 AM - StreetInsider
Form 10-Q Imunon, Inc. For: Mar 31
May 12, 2026 8:46 AM - SEC Filing
Form 8-K Imunon, Inc. For: May 12
May 12, 2026 8:05 AM - SEC Filing
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026 8:00 AM - Globe NewsWire
IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026
May 5, 2026 8:30 AM - Globe NewsWire
Form ARS Imunon, Inc. For: Dec 31
May 4, 2026 4:31 PM - SEC Filing
Form 8-K Imunon, Inc. For: May 01
May 4, 2026 8:01 AM - SEC Filing
Form DEF 14A Imunon, Inc. For: May 04
May 4, 2026 6:31 AM - SEC Filing
Full Article List